(By Dividends4Life) Linked here is a detailed quantitative analysis of Owens & Minor, Inc.
). Below are some highlights from the above linked analysis:Company Description:
Owens & Minor Inc. is a leading domestic distributor of medical and surgical supplies to the acute care market, a health care supply chain management company, and a direct-to-consumer (DTC) supplier of testing and monitoring supplies for diabetes.Fair Value:
In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
OMI is trading at a discount to 1.) and 3.) above. The stock is trading at a slight discount to its calculated fair value of $29.43. OMI earned a Star in this section since it is trading at a fair value.Dividend Analytical Data:
In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
OMI earned one Star in this section for 2.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1926 and has increased its dividend payments for 14 consecutive years. Dividend Income vs. MMA:
Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA
. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:
1. NPV MMA Diff.
2. Years to > MMA
OMI earned a Star in this section for its NPV MMA Diff. of the $2,372. This amount is in excess of the $2,100 target I look for in a stock that has increased dividends as long as OMI has. Memberships and Peers:
.OMI is and a member of the Broad Dividend Achievers™ Index. The company's peer group includes: Cardinal Health, Inc.
) with a 2.2% yield, McKesson Corporation
) with a 0.9% yield and Patterson Companies Inc.
) with a 1.6% yield.Conclusion:
OMI earned one Star in the Fair Value section, earned one Star in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of three Stars. This quantitatively ranks OMI as a 3-Star Hold
Using my D4L-PreScreen.xls
model, I determined the share price would need to increase to $30.31 before OMI's NPV MMA Differential decreased to the $2,100 minimum that I look for in a stock with 14 years of consecutive dividend increases. At that price the stock would yield 2.9%.
Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $2,100 NPV MMA Differential, the calculated rate is 9.5%. This dividend growth rate is below the 10.0% used in this analysis, thus providing a slight margin of safety. OMI has a risk rating
of 1.50 which classifies it as a Low risk stock.
OMI's business is well-insulated from economic cycles and the effects of health-care policy reform, and should enjoy increasing demand for medical/surgical supplies as a result of long-term demographic trends. However, the company lacks a competitive advantage as a middleman in a low-growth business. Near-term results are likely to reflect tougher hospital markets with strong competition leading to less favorable supply contracts. OMI is trading below my $29.43 calculated fair value, but I am in no rush to add to my position.Disclaimer:
Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you
should do your own research and reach your own conclusion. See my Disclaimer
for more information.Full Disclosure:
At the time of this writing, I was long in OMI (1.9% of my Dividend Growth Portfolio). See a list of all my dividend growth holdings